| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |